Elections to the European Association of Percutaneous Cardiovascular Interventions (EAPCI) Board YOUR IDENTITY
|
|
- Dana Hart
- 5 years ago
- Views:
Transcription
1 p Elections to the European Association of Percutaneous Cardiovascular Interventions (EAPCI) Board Application for the following position in the EAPCI Board: Secretary Title: Associate Professor of Medicine Family Name: Stankovic First Name: Goran ESC ID**: Date of birth: YOUR IDENTITY Current Position: Head of Department for invasive diagnostics of the Division of Cardiology, Clinical Center of Serbia Type of Address: Address: Country: Telephone: Mobile Tel: Fax: **If you have no My ESC Account, please register at and click on the top right corner on log in to My ESC (see visual below) 1 EAPCI Board elections Applications
2 ADDITIONAL INFORMATION Your profession Interventionalist Healthcare Professional (Nurse, Radiographer, Technician) working in PCI Industry Professional Other please specify Are you a fellow of the ESC? Yes Are you a member of EAPCI? Yes the member of the Education Committee Are you member of a National Society? Yes Cardiology Society of Serbia Are you member of an Interventional Working Group? Yes Interventional WG of Cardiology Society of Serbia N.B: Letter(s) of support from any relevant group are welcome Letter of support provided to the Chairman of Nominating Committee by Prof. Miodrag Ostojic, President of Interventional WG of Cardiology Society of Serbia 2 EAPCI Board elections Applications
3 GENERAL CV (as it pertains to PCI) (300 words max) I am the Associate professor of internal medicine at the Belgrade University Medical School, Head of Department for invasive diagnostics of Division of Cardiology, Clinical Centre of Serbia. During the period I worked in Columbus and San Raffaele Hospitals in Milan, with position of Research Coordinator. I serve as co-editor of the Cardiology International, and Editorial board member of: JACC, Cardiology International, JAMA-Serbia and Montenegro and Serbian Archives of Medicine and as a reviewer for 14 CC Journals. From 2005 to 2009 years I was elected as Elite Reviewer of JACC. In 2009 I received Simon Dack Award for Outstanding Scholarship from the American College of Cardiology Foundation. I was a member of the Scientific Committee of Serbian Cardiology Congresses in 2003, 2005, 2007 and 2009 and Faculty member on 41 foreign congresses. I had 61 invited lectures and was moderator at 25 international workshops at the field of interventional cardiology dedicated mainly to treatment of bifurcation lesions. I am a member of Serbian Medical Association, Cardiology Society of Serbia, the American College of Cardiology (since FACC), European Society of Cardiology (since FESC) and the European Association for Percutaneous Coronary Interventions (since 2007), where I m the member of the Education Committee. I m one of founding members of European Bifurcation Club and the member of Japanese Bifurcation Club. I am a member of the Committee for creation and implementation of guidelines for good clinical practice in Serbia. I published a as author or co-author more then 100 scientific papers and was located in a group of 20 researchers with the highest impact factor in the Serbian Ministry of Science and Technology Development. In addition, I published as a co-editor with Dr. Antonio Colombo 3 books in the field of interventional cardiology and wrote chapters in 18 books, textbooks and monographs. 3 EAPCI Board elections Applications
4 Publications in the field of PCI (please list 10 max) 1. Stankovic G, Manginas A, Voudris V, Pavlides G, Athanassopoulos G, Ostojic M, Cokkinos DV. Prediction Previous of restenosis experience after coronary in EAPCI, angioplasty ESC or by your use National of a new index: Bodies? TIMI frame count/minimal luminal diameter ratio. Circulation 2000;101: Stankovic G, Colombo A, Presbitero P, van den Branden F, Inglese L, Cernigliaro C, Niccoli L, Bartorelli AL, Rubartelli P, Reifart N, Heyndrickx GR, Saunamaki K, Morice MC, Sgura FA, Di Mario C. Randomized Evaluation of Polytetrafluoroethylene-Covered Stent in Saphenous Vein Grafts: The Randomized Evaluation of polytetrafluoroethylene COVERed stent in Saphenous vein grafts (RECOVERS) Trial. Circulation. 2003;108: Stankovic G, Liistro F, Moshiri S, Briguori C, Corvaja N, Gimelli G, Chieffo A, Montorfano M, Finci L, Spanos V, Di Mario C, Colombo A. Carotid artery stenting in the first 100 consecutive patients: results and follow-up. Heart 2002;88: G. Stankovic, D. Orlic, C. Di Mario, N. Corvaja, F. Airoldi, A. Chieffo, A. Amato, R. Orecchia, A. Colombo. Beta-radiation therapy for long lesions in native coronary vessels. A matched comparison between de novo and in-stent restenotic lesions. Cardiovasc Radiation Med 2003;Vol.4,Issue 1: Stankovic G, Chieffo A, Iakovou I, Orlic D, Corvaja N, Sangiorgi G, Airoldi F, Colombo A. Creatine kinase-myocardial band isoenzyme elevation after percutaneous coronary interventions using sirolimus-eluting stents. Am J Cardiol 2004;93: Stankovic G, Colombo A, Bersin R, Popma J, Sharma S, Cannon LA, Gordon P, Nukta D, Braden G, Collins M. Comparison of directional coronary atherectomy and stenting versus stenting alone for the treatment of de novo and restenotic coronary artery narrowing. Am J Cardiol 2004;93: Stankovic G, Cosgrave J, Chieffo A, Iakovou I, Sangiorgi G, Montorfano M, Airoldi F, Carlino M, Michev I, Finci L, Colombo A. Impact of sirolimus-eluting and Paclitaxel-eluting stents on outcome in patients with diabetes mellitus and stenting in more than one coronary artery. Am J Cardiol 2006;98: Stankovic G, Darremont O, Ferenc M, Hildick-Smith D, Lassen JF, Louvard Y, Albiero R, Pan M, Lefevre T. Percutaneous coronary intervention for bifurcation lesions: Consensus document from the fourth meeting of the European Bifurcation Club. EuroIntervention 2009;5: Stankovic G, Zivkovic M. In-lab high dose clopidogrel loading: Do we need a mirror of diamond for "Armida's garden"? J Am Coll Cardiol 2010;56: Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, Airoldi F, Chieffo A, Montorfano M, Carlino M, Michev I, Corvaja N, Briguori C, Gerckens U, Grube E, Colombo A. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005;293: ; 4 EAPCI Board elections Applications
5 What would you like to achieve if you were elected? (150 words max)? Bring positive spirit of cooperation and friendship between Working Groups of national societies participating in EAPCI; Ensure a transparent process for the development of future EAPCI programs; Actively participate in all activities of the Association: developing guidelines, supporting smaller Working Groups and basic science, awarding fellowships, preparing the certification platform for subspecialty training; Promote and help implementation of the Stent for life project in European countries; Try to involve more interventionalists from eastern European countries in EAPCI activities, especially in education and training programs; Continue collaboration with the President and Board members of EAPCI which had already been started during program preparation of several previous EuroPCR meetings; 5 EAPCI Board elections Applications
Rationale for Percutaneous Revascularization ESC 2011
Rationale for Percutaneous Revascularization Marie Claude Morice, Massy FR MD, FESC, FACC ESC 2011 Paris Villepinte - 27-31 August, 2011 Massy, France Potential conflicts of interest I have the following
More informationIncidence, Predictors, and Outcome of Thrombosis After Successful Implantation of Drug-Eluting Stents JAMA. 2005;293:
BRIEF REPORT Incidence, Predictors, and Outcome of Thrombosis After Successful Implantation of Drug-Eluting Stents Ioannis Iakovou, MD Thomas Schmidt, MD Erminio Bonizzoni, PhD Lei Ge, MD Giuseppe M. Sangiorgi,
More informationEMANUELE BARBATO BELGIUM / ITALY. Application for the following position in the EAPCI Board: SECRETARY. Current position
EMANUELE BARBATO BELGIUM / ITALY Application for the following position in the EAPCI Board: SECRETARY Current position Associate Director of the Cardiovascular Research Center Aalst, OLV Hospital (Belgium)
More informationInt J Clin Exp Med 2017;10(7): /ISSN: /IJCEM Jie Zhou 1, Hui Chen 2
Int J Clin Exp Med 2017;10(7):11220-11225 www.ijcem.com /ISSN:1940-5901/IJCEM0053047 Original Article A real world analysis of the angiographic patterns of in-stent restenosis and clinical outcome of second
More informationLong-term freedom from angina and
Hellenic J Cardiol 2010; 51: 368-373 Case Report The Crush Technique as a Therapeutic Approach for a Bifurcation Lesion in a Saphenous Venous Graft Io a n n i s Ka r a l i s, Ge o r g e Ko c h i a d a
More informationSeeing double: the double kissing crush stenting technique for coronary bifurcation lesions
xxxxxxx editorial Seeing double: the double kissing crush stenting technique for coronary bifurcation lesions In the drug-eluting stent era, interventionalists continue to face the traditional problems:
More informationANGIOPLASY SUMMIT 2007 TCT ASIA PACIFIC. Seoul, Korea: April The problem is exaggerated: Data from Real World Registries
ANGIOPLASY SUMMIT 007 TCT ASIA PACIFIC Seoul, Korea: 5-7 7 April 007 15 min Plenary Session: State-of of-the-art Lectures The problem is exaggerated: Data from Real World Registries Antonio Colombo Centro
More informationRestenosis after implantation of sirolimus-eluting stent begins suddenly, shows short term progression, and stops suddenly
Journal of Cardiology (2011) 58, 26 31 a va i la b le at www.sciencedirect.com jo ur nal home page: www.elsevier.com/locate/jjcc Original article Restenosis after implantation of sirolimus-eluting stent
More informationI have nothing to disclose.
I have nothing to disclose. ESC congress of cardiology, 25-29th August 2012, Munich, Germany Minsk-Village 6, August 26 th, 2:22 PM Session: The grey zone of coronary interventions: The real bifurcation
More informationCURRICULUM VITAE (SUMMARY)
CURRICULUM VITAE (SUMMARY) Full Name: Lino Manuel Martins Gonçalves Birthdate: September 23, 1960 Loulé (Portugal) Civil State: Married Nationality: Portuguese Current Address: Rua Carlos Oliveira, 17,
More informationElections to EACVI Board and Sections
Application for the position: Councillor 1. Your Identity Title: Prof. Dr. Family Name(s): Van de Veire First Name(s): Nico R.L. Birth Date: 23th of June 1975 Type of address: Business/Home? Business Institute/Organisation:
More informationUnprotected LM intervention
Unprotected LM intervention Guideline for COMBAT Seung-Jung Park, MD, PhD Professor of Internal Medicine, Seoul, Korea Current Recommendation for unprotected LMCA Stenosis Class IIb C in ESC guideline
More informationDRUG-COATED BALLOONS AND CORONARY BIFURCATION LESIONS
DRUG-COATED BALLOONS AND CORONARY BIFURCATION LESIONS *Alessandro Durante, 1 Pietro Leonida Laforgia 2 1. Ospedale Valduce, Como, Italy 2. Università degli Studi di Milano, Milan, Italy *Correspondence
More informationLong-Term Outcome of Simultaneous Kissing Stenting Technique With Sirolimus-Eluting Stent for Large Bifurcation Coronary Lesions
Catheterization and Cardiovascular Interventions 70:840 846 (2007) Long-Term Outcome of Simultaneous Kissing Stenting Technique With Sirolimus-Eluting Stent for Large Bifurcation Coronary Lesions Young-Hak
More informationScope of the Problem: DAPT and Triple Therapy after Stenting
Scope of the Problem: DAPT and Triple Therapy after Stenting Kurt Huber, MD, FESC, FACC 3 rd Medical Department Cardiology & Emergency Medicine Wilhelminenhospital Vienna, Austria Session, August 30, 2010,
More informationCouncillor. Elections to EACVI Board and Sections Professor of cardiology. Matskeplishvili. Simon
Application for the position: Councillor 1. Your Identity Title: Family Name(s): First Name(s): Professor of cardiology Matskeplishvili Simon Birth Date: December 15, 1972 Type of address: Business Institute/Organization:
More informationModified Flower Petal Technique
JACC: CARDIOVASCULAR INTERVENTIONS VOL. 6, NO. 5, 2013 2013 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 1936-8798/$36.00 PUBLISHED BY ELSEVIER INC. http://dx.doi.org/10.1016/j.jcin.2012.12.130
More informationDrug Eluting Stents Sometimes Fail ESC Stockholm 29 Set 2010 Stent Thrombosis Alaide Chieffo
Drug Eluting Stents Sometimes Fail ESC Stockholm 29 Set 2010 Stent Thrombosis 11.45-12.07 Alaide Chieffo San Raffaele Scientific Institute, Milan, Italy Historical Perspective 25 20 15 10 5 0 Serruys 1991
More informationEUROPEAN HEART RHYTHM ASSOCIATION A Registered Branch of the ESC
Application for the following position in the EHRA Board: Treasurer 1. Your Identity Title: Prof., MD, PhD, FESC Family Name(s): Raatikainen First Name(s): Matti Jukka Pekka Birth Date: April 3, 1963 Type
More informationPaclitaxel-Eluting Coronary Stents in Patients With Diabetes Mellitus
Journal of the American College of Cardiology Vol. 51, No. 7, 2008 2008 by the American College of Cardiology Foundation ISSN 0735-1097/08/$34.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2007.10.035
More informationProtection of side branch is essential in treating bifurcation lesions: overview
Angioplasty Summit TCT Asia Pacific Seoul, April 26-28, 2006 Protection of side branch is essential in treating bifurcation lesions: overview Alfredo R Galassi, MD, FACC, FSCAI, FESC Head of the Catetherization
More informationPericardial Covered Stent for Coronary Perforations
Catheterization and Cardiovascular Interventions 00:00 00 (2015) Original Studies Pericardial Covered Stent for Coronary Perforations Shmuel Chen, 1 MD, Chaim Lotan, 1 MD, Ronen Jaffe, 2 MD, Ronen Rubinshtein,
More informationInterventional Cardiology
Interventional Cardiology Randomized Study of the Crush Technique Versus Provisional Side-Branch Stenting in True Coronary Bifurcations The CACTUS (Coronary Bifurcations: Application of the Crushing Technique
More informationLM stenting - Cypher
LM stenting - Cypher Left main stenting with BMS Since 1995 Issues in BMS era AMC Restenosis and TLR (%) 3 27 TLR P=.282 Restenosis P=.71 28 2 1 15 12 Ostium 5 4 Shaft Bifurcation Left main stenting with
More informationTechnical considerations in the Treatment of Left Main Lesions Ioannis Iakovou, MD, PhD
Technical considerations in the Treatment of Left Main Lesions Ioannis Iakovou, MD, PhD Onassis Cardiac Surgery Center, Athens, Greece Critical issues in LM PCI Anatomic variability Techniques Variability
More informationSirolimus-Eluting Stent Implantation for Ostial Left Anterior Descending Coronary Artery Lesions Three-Year Outcome From the j-cypher Registry
Sirolimus-Eluting Stent Implantation for Ostial Left Anterior Descending Coronary Artery Lesions Three-Year Outcome From the j-cypher Registry Koichi Kishi, MD; Takeshi Kimura, MD; Takeshi Morimoto, MD;
More informationJACC: CARDIOVASCULAR INTERVENTIONS VOL. 1, NO. 3, PUBLISHED BY ELSEVIER INC. DOI: /j.jcin
JACC: CARDIOVASCULAR INTERVENTIONS VOL. 1, NO. 3, 2008 2008 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 1936-8798/08/$34.00 PUBLISHED BY ELSEVIER INC. DOI: 10.1016/j.jcin.2007.12.008 What Do
More informationLesions at coronary bifurcations represent a challenging
Randomized Study to Evaluate Sirolimus-Eluting Stents Implanted at Coronary Bifurcation Lesions Antonio Colombo, MD; Jeffrey W. Moses, MD; Marie Claude Morice, MD; Josef Ludwig, MD; David R. Holmes, Jr,
More informationImportant LM bifurcation studies update
8 th European Bifurcation Club 12-13 October 2012 - Barcelona Important LM bifurcation studies update I Sheiban E-mail: isheiban@yahoo.com Unprotected LM Percutaneous Revascularization What is important
More informationUpdate. 1 Institute of Cardiology G. d Annunzio University Chieti; 2 Laboratory of Interventional Cardiology and Department of Cardiology, Clinica
Update Marco Zimarino 1, MD, PhD, Carlo Briguori 2, MD; Robert J Gil 3, MD, Francesco Radico 1, MD, Ignacio J Amat-Santos 4, Emanuele Barbato 5,6, MD, PhD, Andrejs Erglis 7, MD, Habib Gamra 8, MD, Francesca
More informationPCI for LMCA lesions A Review of latest guidelines and relevant evidence
HCS Working Group Seminars Met Hotel, Thursday 14 th February 2013 PCI for LMCA lesions A Review of latest guidelines and relevant evidence Vassilis Spanos Interventional Cardiologist, As. Director 3 rd
More informationUnprotected Left Main Stenting: Patient Selection and Recent Experience. Alaide Chieffo. S. Raffaele Hospital, Milan, Italy
Unprotected Left Main Stenting: Patient Selection and Recent Experience Alaide Chieffo S. Raffaele Hospital, Milan, Italy Class IIa (Level B) AHA/ACC 2005 Guidelines Left Main CAD The use of PCI for pts
More informationSupplementary Online Content
Supplementary Online Content Valle JA, Tamez H, Abbott JD, et al. Contemporary use and trends in unprotected left main coronary artery percutaneous coronary intervention in the United States: an analysis
More informationJournal of the American College of Cardiology Vol. 48, No. 2, by the American College of Cardiology Foundation ISSN /06/$32.
Journal of the American College of Cardiology Vol. 48, No. 2, 2006 2006 by the American College of Cardiology Foundation ISSN 0735-1097/06/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2006.03.039
More informationComparison of Sirolimus Versus Paclitaxel Eluting Stents for Treatment of Coronary in-stent Restenosis F. Airoldi, et al. Am J Cardiol (2006)
Comparison of Sirolimus Versus Paclitaxel Eluting Stents for Treatment of Coronary in-stent Restenosis F. Airoldi, et al. Am J Cardiol (2006) 97;1182-7 n&list_uids=16616023 Value of the American College
More informationJournal of the American College of Cardiology Vol. 47, No. 7, by the American College of Cardiology Foundation ISSN /06/$32.
Journal of the American College of Cardiology Vol. 47, No. 7, 2006 2006 by the American College of Cardiology Foundation ISSN 0735-1097/06/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.05.102
More informationKonstantinos Toutouzas
Konstantinos Toutouzas Greece Application for the following position in the EAPCI Board: TREASURER Current position Associate professor of Cardiology, Athens Medical School, Athens, Greece Profession Interventionalist.
More informationElections to EACVI Board
Elections to EACVI Board 2018-2020 Application for the position: EACVI Vice-President-Elect (Echocardiography) 1. Your Identity Title Family Name(s) First Name(s) Professor of Cardiology Sade Leyla Elif
More informationTemporal Relation Between Clopidogrel Cessation and Stent Thrombosis After Drug-Eluting Stent Implantation
Temporal Relation Between Clopidogrel Cessation and Stent Thrombosis After Drug-Eluting Stent Implantation Probal Roy, MD, Laurent Bonello, MD, Rebecca Torguson, MPH, Teruo Okabe, MD, Tina L. Pinto Slottow,
More informationTurbo-Power. Laser atherectomy catheter. The standard. for ISR
Turbo-Power Laser atherectomy catheter The standard for ISR Vaporize the ISR challenge In-stent restenosis (ISR) Chance of recurring 7 115,000 + /year (U.S.) 1-6 Repeated narrowing of the arteries after
More informationC arotid endarterectomy has been shown to be superior to
381 INTERVENTIONAL CARDIOLOGY AND SURGERY Carotid artery stenting in the first 100 consecutive patients: results and follow up G Stankovic, F Liistro, S Moshiri, C Briguori, N Corvaja, G Gimelli, A Chieffo,
More informationOne-Year Outcomes After Everolimus-Eluting Stents Implantation in Ostial Lesions of Left Anterior Descending Coronary Arteries
Elmer Press Original Article One-Year Outcomes After Everolimus-Eluting Stents Implantation in Ostial Lesions of Left Anterior Descending Coronary Arteries Zahra Golmohamadi a, c, Sepideh Sokhanvar b,
More informationEfficacy of Drug-Eluting Stents for Treating In-Stent Restenosis of Drug-Eluting Stents (from the Korean DES ISR Multicenter Registry Study [KISS])
Efficacy of Drug-Eluting Stents for Treating In-Stent Restenosis of Drug-Eluting Stents (from the Korean DES ISR Multicenter Registry Study [KISS]) Young-Guk Ko, MD a, Jung-Sun Kim, MD, PhD a, Byeong-Keuk
More informationAngiographic and Intravascular Ultrasound Predictors of In-Stent Restenosis
1630 JACC Vol. 32, No. 6 Angiographic and Intravascular Ultrasound Predictors of In-Stent Restenosis SHUNJI KASAOKA, MD, JONATHAN M. TOBIS, MD, FACC, TATSURO AKIYAMA, MD,* BERNHARD REIMERS, MD,* CARLO
More informationStent Thrombosis in Bifurcation Stenting
Summit TCT Asia Pacific 2009 Stent Thrombosis in Bifurcation Stenting Associate Professor Tan Huay Cheem MBBS, M Med(Int Med), MRCP, FRCP(UK), FAMS, FACC, FSCAI Director, National University Heart Centre,
More informationConsensus so far and what we will be focusiong on this time
Consensus so far and what we will be focusiong on this time The 6 th European Bifurcation Club Meeting Budapest October 22-23 2010 Jens Flensted Lassen, MD, PH.D., FESC. Department of Cardiology B Skejby
More informationSunao Nakamura M.D,Ph.D.
Drug Eluting Stent Implantation For Unprotected Left ain Coronary Arteries New Tokyo Circulation Research Group New Tokyo Hospital Sunao Nakamura.D,Ph.D. Drug-Eluting Stent for Left ain Coronary Artery
More informationDrug eluting stents: Focus on Cypher sirolimuseluting coronary stents in the treatment of patients with bifurcation lesions
REVIEW Drug eluting stents: Focus on Cypher sirolimuseluting coronary stents in the treatment of patients with bifurcation lesions Alaide Chieffo Tiziana Claudia Aranzulla Antonio Colombo Interventional
More informationIntra-Procedural Stent Thrombosis
JACC: CARDIOVASCULAR INTERVENTIONS VOL. 6, NO. 1, 2013 2013 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 1936-8798/$36.00 PUBLISHED BY ELSEVIER INC. http://dx.doi.org/10.1016/j.jcin.2012.08.018
More informationLong-Term Clinical Outcome After a First Angiographically Confirmed Coronary Stent Thrombosis An Analysis of 431 Cases
Long-Term Clinical Outcome After a First Angiographically Confirmed Coronary Stent Thrombosis An Analysis of 431 Cases Jochem W. van Werkum, MD, PhD; Antonius A.C.M. Heestermans, MD; Fleur I. de Korte,
More informationKomplexe Koronarintervention heute: Von Syntax zu bioresorbierbaren Stents
Komplexe Koronarintervention heute: Von Syntax zu bioresorbierbaren Stents Prof. Dr. med. Julinda Mehilli Medizinische Klinik und Poliklinik I Klinikum der Universität München Campus Großhadern Key Factors
More informationJournal of the American College of Cardiology Vol. 46, No. 5, by the American College of Cardiology Foundation ISSN /05/$30.
Journal of the American College of Cardiology Vol. 46, No. 5, 2005 2005 by the American College of Cardiology Foundation ISSN 0735-1097/05/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.06.009
More informationClinical Policy Title: Brachytherapy of coronary arteries
Clinical Policy Title: Brachytherapy of coronary arteries Clinical Policy Number: 04.02.04 Effective Date: January 1, 2016 Initial Review Date: September 16, 2015 Most Recent Review Date: October 19, 2017
More informationDrug-eluting stents (DES) reduce the rate of restenosis and
Original Articles Mechanisms of In-Stent Restenosis After Drug-Eluting Stent Implantation Intravascular Ultrasound Analysis Soo-Jin Kang, MD; Gary S. Mintz, MD; Duk-Woo Park, MD; Seung-Whan Lee, MD; Young-Hak
More informationHCS Working Group Seminars Macedonia Pallas Hotel, Friday 21 st February Drug-eluting stents Are they all equal?
HCS Working Group Seminars Macedonia Pallas Hotel, Friday 21 st February 2014 Drug-eluting stents Are they all equal? Vassilis Spanos Interventional Cardiologist, As. Director 3 rd Cardiology Clinic Euroclinic
More informationMulticenter Clinical Trial on the Impact of Biomechanical Factors on Bifurcation Stent Restenosis and Thrombosis
11th EBC, Athens, Greece September 25 & 26, 2015 Multicenter Clinical Trial on the Impact of Biomechanical Factors on Bifurcation Stent Restenosis and Thrombosis Yiannis S. Chatzizisis, MD, PhD Associate
More informationOUTCOMES WITH LONGTERM DUAL ANTIPLATELET THERAPY AFTER CORONARY ANGIOPLASTY Ashok Kumar Arigonda, K. Nagendra Prasad, O. Hareesh, R.
INDIAN JOURNAL OF CARDIOVACULAR DIEAE JOURNAL in women (IJCD) 016 VOL 1 IUE 3 ORIGINAL ARTICLE 1 OUTCOME WITH LONGTERM DUAL ANTIPLATELET THERAPY AFTER CORONARY ANGIOPLATY Ashok Kumar Arigonda, K. Nagendra
More informationAbstract Aims: To evaluate the feasibility and safety of the Nile Croco coronary bifurcation stent system (Minvasys, C L I N I C A L R E S E A R C H
C L I N I C A L R E S E A R C H Clinical and procedural evaluation of the Nile Croco dedicated stent for bifurcations: results of one centre s initial experience with the first 151 consecutive non-selected
More informationCoronary artery disease (CAD) is
Hellenic J Cardiol 2012; 53: 480-484 Case Report Unprotected Left Main Distal Bifurcation Lesion George Karavolias, Panagiotis Karyofillis, Panagiota Georgiadou, Vassilis Voudris Second Department of Interventional
More informationAbstract Background: Methods: Results: Conclusions:
Two-Year Clinical and Angiographic Outcomes of Overlapping Sirolimusversus Paclitaxel- Eluting Stents in the Treatment of Diffuse Long Coronary Lesions Kang-Yin Chen 1,2, Seung-Woon Rha 1, Yong-Jian Li
More information[ Original article ] Keywords INTRODUCTION
Acta Cardiol 2013; 68(1): 1-9 doi: 10.2143/AC.68.1.2959625 1 [ Original article ] Long-term follow-up after percutaneous coronary intervention with polytetrafluoroethylene-covered Symbiot TM stents compared
More informationThe jailed side branch and OCT guided cross over. Accidental abluminal rewiring, OCT check or optimal technique?
Friday October 18th EBC 2013 FINAL PROGRAMME Morning 09:00-09:30 EBC board meeting 09:30-11:30 Abbott meeting with EBC Board 10:30-12:30 St Jude Medical pre-meeting 12:00 13:00 - WELCOME LUNCH PARALLEL
More informationPredictors of Reocclusion After Successful Drug-Eluting Stent Supported Percutaneous Coronary Intervention of Chronic Total Occlusion
Journal of the American College of Cardiology Vol. 61, No. 5, 2013 2013 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.10.036
More informationThe time period between the first
Review Article Hellenic J Cardiol 2010; 51: 512-517 The Ever Increasing Role of Percutaneous Interventions in Coronary Revascularisation Vassilis N. Spanos, Pavlos K. Toutouzas Cardiology Department, Euroclinic
More informationC. W. Hamm, B. Cremers, H. Moellmann, S. Möbius-Winkler, U. Zeymer, M. Vrolix, S. Schneider, U. Dietz, M. Böhm, B. Scheller
Paclitaxel-Eluting PTCA-Balloon in Combination with the Coroflex Blue Stent vs the Sirolimus Coated Cypher Stent in the Treatment of Advanced Coronary Artery Disease C. W. Hamm, B. Cremers, H. Moellmann,
More informationCoronary Revascularization for Patients with Severe Coronary Artery Disease: An Overview of Current Evidence and Treatment Strategies
Review J Jpn Coron Assoc 2015; 21: 267-271 Coronary Revascularization for Patients with Severe Coronary Artery Disease: An Overview of Current Evidence and Treatment Strategies Hiroki Shiomi, Takeshi Kimura
More informationFinal Clinical and Angiographic Results From a Nationwide Registry of FIREBIRD Sirolimus- Eluting Stent: Firebird In China (FIC) Registry (PI R. Gao)
The Microport FIREBIRD Polymer-based Sirolimus- Eluting Stent Clinical Trial Program Update: The FIC and FIREMAN Registries Junbo Ge, MD, FACC, FESC, FSCAI On behalf of Runlin Gao (FIC PI) and Haichang
More informationImpact of Chronic Kidney Disease on Long-Term Outcome in Coronary Bypass Candidates Treated with Percutaneous Coronary Intervention
Original Article Print ISSN 1738-5520 On-line ISSN 1738-5555 Korean Circulation Journal Impact of Chronic Kidney Disease on Long-Term Outcome in Coronary Bypass Candidates Treated with Percutaneous Coronary
More informationARMYDA-RECAPTURE (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) trial
ARMYDA-RECAPTURE ( for Reduction of MYocardial Damage during Angioplasty) trial Prospective, multicenter, randomized, double blind trial investigating efficacy of atorvastatin reload in patients on chronic
More informationThe 3 top Messages from technique Specific problems Solving
The 3 top Messages from technique Specific problems Solving Alaide Chieffo Interventional Cardiology Unit San Raffaele Hospital Milan - Italy PROBLEMS DURING PROVISIONAL: SB PROTECTION AND RESCUE Francesco
More informationInterventional Cardiology
Interventional Cardiology Randomized Comparison of Everolimus-Eluting and Paclitaxel-Eluting Stents Two-Year Clinical Follow-Up From the Clinical Evaluation of the Xience V Everolimus Eluting Coronary
More informationFreedom to Treat Your High Bleeding Risk Patients. Tim Kinnaird University Hospital of Wales, Cardiff, UK
Freedom to Treat Your High Bleeding Risk Patients Tim Kinnaird University Hospital of Wales, Cardiff, UK Relevant Disclosures Honoraria for lectures from: o Eli Lilly & Co, Daiichi Sankyo, Boehringer,
More informationClinical Outcome After Crush Versus Culotte Stenting of Coronary Artery Bifurcation Lesions
JACC: CARDIOVASCULAR INTERVENTIONS VOL. 6, NO. 11, 2013 ª 2013 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 1936-8798/$36.00 PUBLISHED BY ELSEVIER INC. http://dx.doi.org/10.1016/j.jcin.2013.06.009
More informationAntiplatelet therapy in myocardial infarction and coronary stent thrombosis Heestermans, Antonius Adrianus Cornelius Maria
University of Groningen Antiplatelet therapy in myocardial infarction and coronary stent thrombosis Heestermans, Antonius Adrianus Cornelius Maria IMPORTANT NOTE: You are advised to consult the publisher's
More informationDES in Diabetic Patients
DES in Diabetic Patients Charles Chan, M.D., FACC Gleneagles Hospital Singapore TCT ASIA PACIFIC 2007 Why do diabetics have worse outcome after PCI? More extensive atherosclerosis and diffuse disease Increase
More informationPercutaneous coronary interventions in Assam, North East India: procedure indications and outcome
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 15, Issue 1 Ver. II (Jan. 2016), PP 29-33 www.iosrjournals.org Percutaneous coronary interventions in
More informationCase Report Left Main Stenosis. Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Graft Surgery (CABG)?
Cronicon OPEN ACCESS CARDIOLOGY Case Report Left Main Stenosis. Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Graft Surgery (CABG)? Valentin Hristov* Department of Cardiology, Specialized
More informationIn-Stent Restenosis. Can we kill it?
In-Stent Restenosis Can we kill it? However, In-stent Restenosis is the most serious problem (2-25%) More than 15, lesions will need treatment because of in-stent restenosis. Varying Prevalence Rates of
More informationClinical Investigations
Clinical Investigations Clinical Outcomes for Single Stent and Multiple Stents in Contemporary Practice Qiao Shu Bin, MD; Liu Sheng Wen, MD; Xu Bo, BS; Chen Jue, MD; Liu Hai Bo, MD; Yang Yue Jin, MD; Chen
More informationTreatment of lesions at bifurcations: General perspective
ESC Congress 2011 27-31 August, Paris, France Treatment of lesions at bifurcations: General perspective Goran Stankovic MD, PhD, FESC Division of Cardiology Clinical Center of Serbia, Belgrade Serbia Potential
More informationRCA Disease and Unprotected LM Stenting
Original Article RCA Disease and Unprotected LM Stenting Acta Cardiol Sin 2011;27:14 20 Coronary Heart Disease The Clinical Significance of Right Coronary Artery Stenosis on the Prognosis of Patients with
More informationJournal of the American College of Cardiology Vol. 47, No. 8, by the American College of Cardiology Foundation ISSN /06/$32.
Journal of the American College of Cardiology Vol. 47, No. 8, 2006 2006 by the American College of Cardiology Foundation ISSN 0735-1097/06/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.11.066
More informationStrategies for PCI of SVG
Strategies for PCI of SVG Ron Waksman, MD, FACC Augusto Pichard, MD, FACC Washington Hospital Center, Washington DC OPTIONS FOR IMPROVED OUTCOMES IN SVG PCI Direct Stenting Thrombus Management Embolic
More informationNon-LM bifurcation studies of importance in 2011
7th European Bifurcation Club 14-15 October 2011 LISBON Goran Stankovic MD, PhD Non-LM bifurcation studies of importance in 2011 October 15 th : 08:00 08:10 DKCRUSH-II: A Prospective Randomized Trial of
More informationLong-term outcomes of simple crossover stenting from the left main to the left anterior descending coronary artery
ORIGINAL ARTICLE Korean J Intern Med 2014;29:597-602 Long-term outcomes of simple crossover stenting from the left main to the left anterior descending coronary artery Ho-Myung Lee 1,*, Chang-Wook Nam
More informationElections to EACVI Board
Elections to EACVI Board 2018-2020 Application for the position: EACVI Councillor (Echocardiography) 1. Your Identity Title Family Name(s) First Name(s) M.D., Ph.D. Muraru Denisa Birth Date 03 April 1979
More informationChristopher S. Lichtenwalter, M.D.
10238 East Hampton, Ste 501 (480) 889-1573 (office) Mesa, AZ 85209 (480) 889-1574 (fax) Current Employment: C.A.I. The Cardiovascular and Arrhythmia Institute General and Interventional Cardiologist; July
More informationAre We Making Progress With Percutaneous Saphenous Vein Graft Treatment? A Comparison of 1990 to 1994 and 1995 to 1998 Results
Journal of the American College of Cardiology Vol. 38, No. 1, 2001 2001 by the American College of Cardiology ISSN 0735-1097/01/$20.00 Published by Elsevier Science Inc. PII S0735-1097(01)01324-9 Are We
More informationPrevention of Coronary Stent Thrombosis and Restenosis
Prevention of Coronary Stent Thrombosis and Restenosis Seong-Wook Park, MD, PhD, FACC Division of Cardiology, Asan Medical Center University of Ulsan College of Medicine, Seoul, Korea 9/12/03 Coronary
More informationRecent advances in technology, devices, and operator
Unprotected Left Main Stenting in the Real World Two-Year Outcomes of the French Left Main Taxus Registry Beatriz Vaquerizo, MD; Thierry Lefèvre, MD; Olivier Darremont, MD; Marc Silvestri, MD; Yves Louvard,
More informationPCI for In-Stent Restenosis. CardioVascular Research Foundation
PCI for In-Stent Restenosis ISR of BMS Patterns of In-Stent Restenosis Pattern I : Focal Type IA: Articulation / Gap Type IB: Marginal Type IC: Focal body Type ID: Multifocal Pattern II,III,IV : Diffuse
More informationPCI for Bifurcation Coronary Lesion
PCI for Bifurcation Coronary Lesion Bifurcation Lesions PCI is Challenging Higher acute complication Lower success rates Higher restenosis & TLR Restenosis Rate 21 ~ 57% TLR 8 ~ 43% Event Free Survival
More informationMaintenance of Long-Term Clinical Benefit With Sirolimus-Eluting Stents in Patients With ST-Segment Elevation Myocardial Infarction
Journal of the American College of Cardiology Vol. 55, No. 8, 2010 2010 by the American College of Cardiology Foundation ISSN 0735-1097/10/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2009.09.046
More informationDeutsches Herzzentrum München and 1. Klinikum rechts der Isar, Technische Universität, Lazarettstrasse 36, Munich, Germany
European Heart Journal (2008) 29, 2868 2876 doi:10.1093/eurheartj/ehn512 CLINICAL RESEARCH Interventional cardiology Culotte stenting technique in coronary bifurcation disease: angiographic follow-up using
More informationEAPCI 2018 Expert Consensus Document on Clinical Use of Intracoronary Imaging Giulio Guagliumi, MD FESC
EAPCI 2018 Expert Consensus Document on Clinical Use of Intracoronary Imaging Giulio Guagliumi, MD FESC EAPCI Scientific Document Committee Robert Byrne, MD Davide Capodanno, MD Motivation The clinical
More informationComparison of Coronary Artery Bypass Grafting With Drug-Eluting Stent Implantation for the Treatment of Multivessel Coronary Artery Disease
Comparison of Coronary Artery Bypass Grafting With Drug-Eluting Stent Implantation for the Treatment of Multivessel Coronary Artery Disease Jeong Hoon Yang, MD, Hyeon-Cheol Gwon, MD, Soo Jin Cho, MD, Joo
More information2010 Korean Society of Cardiology Spring Scientific Session Korea Japan Joint Symposium. Seoul National University Hospital Cardiovascular Center
2010 Korean Society of Cardiology Spring Scientific Session Korea Japan Joint Symposium Does Lt Late Cth Catch up Exist Eiti in DES? : Quantitative Coronary Angiography Analysis Kyung Woo Park, MD Cardiovascular
More informationFrequency of and Risk Factors for Stent Thrombosis After Drug-Eluting Stent Implantation During Long-Term Follow-Up
Frequency of and Risk Factors for Stent Thrombosis After Drug-Eluting Stent Implantation During Long-Term Follow-Up Duk-Woo Park, MD, Seong-Wook Park, MD, PhD*, Kyoung-Ha Park, MD, Bong-Ki Lee, MD, Young-Hak
More informationLong-Term Clinical Outcomes of Sirolimus- Versus Paclitaxel-Eluting Stents for Patients With Unprotected Left Main Coronary Artery Disease
Journal of the American College of Cardiology Vol. 54, No. 9, 2009 2009 by the American College of Cardiology Foundation ISSN 0735-1097/09/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2009.04.071
More informationLong-term outcomes of PCI vs. CABG for ostial/midshaft lesions in unprotected left main coronary artery
Journal of Geriatric Cardiology (2017) 14: 254 260 2017 JGC All rights reserved; www.jgc301.com Research Article Open Access Long-term outcomes of PCI vs. CABG for ostial/midshaft lesions in unprotected
More information